Arkolith/Insider Trading/AVLN/Form 4

SR One Capital Management, LLC

10% OwnerAvalyn Pharma Inc. (AVLN) · full profile →Form 4 · filed May 1, 2026
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
10
6 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Conversion(C)1.4M——1.4M
May 1, 2026Conversion(C)489K——1.9M
May 1, 2026Buy(P)278K$18.00$5.0M2.2M
May 1, 2026Conversion(C)355K——355K
May 1, 2026Conversion(C)489K——844K
May 1, 2026Buy(P)278K$18.00$5.0M1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2026Conversion(C)27.3M——0
May 1, 2026Conversion(C)9.4M——0
May 1, 2026Conversion(C)6.8M——0
May 1, 2026Conversion(C)9.4M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-201887) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML